2021 annual financial data
Janux Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -32,929,000 USD and net income was -32,559,000 USD.
Operating cash flow was Not available.
Get free Janux Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,637,000 USD
- Operating income
- -32,929,000 USD
- Net income
- -32,559,000 USD
- Operating cash flow
- Not available